Schlagwort: Europe
Part III: The Best Asset Doesn’t Have a Passport
For many years, Western biotech companies viewed China primarily as a manufacturing base and, increasingly, as an attractive commercial market. Today, that perspective is...
‘‘We build a leading global platform for precision healthcare‘‘
Leo International Precision Health AG (LIPH) is an investment holding company (WKN: 549060; ticker: LEOW) that has been listed on the stock exchange since...
Protecting Innovation: Intellectual Property Insurance – the Emerging Essential
In a global, innovation-driven economy, intangible assets such as patents, trademarks, and know-how often account for half or more of a company’s value. In...
Mallia setzt auf prominente Köpfe
Mallia bereitet sich auf den Marktstart seiner ersten kosmetischen Produkte zur Förderung des Haarwachstums vor. Parallel dazu stellt das Unternehmen einen prominent besetzten Beirat...
Organoids and organs on chips – an emerging biotech/pharma business
Organoids or organs-on-chips (OoCs) are two types of three-dimensional tissue culture systems amenable for the study of complex human physiological functions. Regulators increasingly recognize...
How to access the public US capital market without an IPO?
European medtech and biotech companies might find engaging in a reverse merger (RM) with a US-based Nasdaq-listed company to be an appealing alternative to...
Pioneering sustainable solutions for protein production
With 80% of agricultural land already used for livestock farming, there is limited scope for further expansion to meet the expected 78% increase in...
Reimagining meat
Plant-based and cultivated meat are essential for meeting our climate targets because they can deliver the meat people want with up to 92% less...
The number of circular economy start-ups in Germany is growing
In the last years, the number of circular economy start-ups in Germany has increased significantly. There are too many different very heterogenous definitions to...
Minimising risks
Like every other industry, the bioeconomy is facing its own challenges. However, as in any other sector, these challenges are being tackled in a...